Cutting-edge technology, featured by Harvard Business School, enables us to scale our unconflicted & comprehensive research across 10,000+ stocks, ETFs, and mutual funds. Learn more. Get a free trial. See Barron’s features of our research. This paper compares our analytics on a mega cap company to other major providers. The Appendix details exactly how we stack up.
Competition Will Eat This Firm Alive
You Won’t Find a Bargain With This Car Dealer
S&P 500 Peaks As Earnings Trough
This Online Retailer Is Furnishing Investors With Risk
Covid-19 Drives Record Write-downs in 1H2020
Competitive Advantages Drive Sweet Growth Opportunities
Tesla: The Most Dangerous Stock for Fiduciaries
Put Your Chips on the Table With This Semiconductor Firm
Rocket Companies is Profitable But Still Expensive
Refuel Your Portfolio with This Leading Operator
Don’t Forgo Diligence: This Fund’s Strategy Doesn’t Hold Up
Despite its 4-Star Morningstar rating, JPMorgan Mid Cap Growth Fund (OSGIX) is in the New Constructs Danger Zone.